Advertisement

Diabetology International

, Volume 6, Issue 4, pp 239–242 | Cite as

Cellular stress response pathways and diabetes mellitus

  • Eiichi ArakiEmail author
  • Tatsuya Kondo
  • Hirofumi Kai
Editorial
  • 624 Downloads

Keywords

Insulin resistance Heat shock protein HSP72 Metabolic syndrome Type 2 diabetes 

Type 2 diabetes, insulin resistance, and heat shock proteins

Type 2 diabetes mellitus is a typical lifestyle-related disease, caused by impaired insulin secretion and insulin resistance. Both of these abnormalities are influenced by environmental and genetic factors. Insulin resistance is caused by impaired insulin signaling pathways, and recent studies have shown that increased inflammatory signals are involved in this phenomena [1].

In conditions with increased visceral fat accumulation, increased stress signals and increased inflammatory cytokines activate stress-induced kinases, such as c-Jun N-terminal kinase (JNK). JNK is reported to induce serine phosphorylation of insulin receptor substrate (IRS)-1, one of the major substrates of the insulin receptor tyrosine kinase, which results in reduced tyrosine phosphorylation of the substrate and finally causes impaired insulin signaling. JNK also activates NF-κB (nuclear factor kappa-B) signals and increases the expression of tumor necrosis factor (TNF)-α and C-reactive protein (CRP). Since TNF-α is known to stimulate JNK, vicious cycles to increase insulin resistance thus are enhanced [2].

Heat shock proteins (HSPs) are molecular chaperones induced by various environmental changes such as elevated temperature, toxins, oxidants and bacterial/viral infections, and they play essential roles in the proper synthesis, transport and folding of proteins [3]. The induction of this cellular stress response pathway (heat shock response pathway) is mainly mediated through the activation of a transcription factor termed heat shock factor-1 (HSF-1). Under stressed conditions, HSF-1 forms a trimer and accumulates in the nucleus, and it binds to its cis-acting element, termed the heat shock element (HSE) or heat response element (HRE), which is located in the 5′-flanking region of heat shock-responsive genes including the HSP70 family [4].

It was reported that the expression of HSP72 mRNA, a member of the HSP70 family, was reduced in subjects with type 2 diabetes [5]. The detailed mechanism of the decreased expression of HSP72 in subjects with type 2 diabetes has not been clarified yet, but it was reported that the trimer formation of HSF-1 is dependent, at least in part, on the inactivation of glycogen synthase kinase (GSK)-3β. Because the inactivation of GSK-3β depends on the activation of phosphatidylinositol (PI)-3 kinase and the Akt pathway, which is located downstream of insulin signaling, an impaired insulin signal may suppress the trimer formation of HSF-1 and result in decreased expression of the HSP72 gene [6] (Fig. 1).
Fig. 1

Insulin signaling pathway and induction of HSP 72 gene, and those under stressed conditions. Under normal conditions, insulin binds to the insulin receptor and activates its tyrosine kinase, which in turn causes the tyrosine phosphorylation of IRS-1. The p85 regulatory subunit of PI-3 kinase recognizes and binds to the specific tyrosine residues of IRS-1, which leads to the activation of PI-3 kinase and the following PDK-1/Akt signaling cascade. Activation of Akt causes the serine phosphorylation and inactivation of GSK-3β, which results in the dephosphorylation and trimerization of HSF-1 followed by transcriptional activation of the HSP72 gene (shown by light green lines). Under conditions of type 2 diabetes or metabolic syndrome, chronic inflammation and stress signals are activated, and the stress-induced activation of JNK causes the serine phosphorylation and inhibits the tyrosine phosphorylation of IRS-1, which finally suppresses the insulin signaling pathway mentioned above and attenuates HSP72 gene expression. JNK also activates the NK-kB pathway and causes the induction of TNF-α and CRP, which further activates stress signals (shown by red lines). Because HSP72 protects cells in part by suppressing the JNK and/or NF-kB activity, decreased expression of HSP72 under such conditions could cause a vicious cycle

Increased expression of HSP72 ameliorates insulin resistance in animal models of type 2 diabetes

We and others have reported previously that an increased expression of HSP72 could ameliorate insulin resistance and improve glycemic control in animal models of obese type 2 diabetes. Chung J et al. reported that transgenic overexpression of HSP72 protein in skeletal muscle or pharmacological means to induce HSP72 protein could protect against the insulin resistance and hyperglycemia in high-fat fed mice, or in ob/ob mice [7]. Henstridge et al. further showed that such induction of HSP72 increased the skeletal mitochondria number and oxidative capacity, and resulted in the amelioration of insulin resistance [8]. Gupte et al. showed that a heat treatment improved glucose tolerance and insulin resistance in high-fat-fed rats [9]. We have shown that a combination of heat shock treatment (HS) and mild electrical stimulation (MES) [42 °C pads and 12-V direct current (55 pulses/s with 0.1-ms duration) for 10 min, twice per week] could effectively induce HSP72 mRNA and protein in high-fat-fed mice, which resulted in improved insulin signaling and glycemic control with decreased visceral fat [10]. In this method, MES (12-V direct current, 55 pulses/s with 0.1-ms duration) enhances heat induction of HSP72 at least in part by a suppression of HSP72 degradation [11] and may also activate insulin signaling by modulating the membrane localization of the insulin receptor [12]. We also showed that oral administration of geranylgeranylacetone (GGA), a chemical inducer of HSP72, induced HSP72 protein in liver and amelioration of insulin resistance and hyperglycemia in high-fat-fed mice [13]. In addition to the amelioration of glucose tolerance, we reported an improved β-cell function, assessed by endoplasmic reticular (ER) stress markers, apoptosis signals and insulin content, in db/db mice treated with HS + MES [14]. These reports suggest the possibility of activation of the heat shock response pathway and/or HSP72 induction for the treatment of type 2 diabetes in humans.

Human subjects with metabolic syndrome or type 2 diabetes and HSP72

In 1999, Hooper et al. reported an improvement of glycemic control in subjects with type 2 diabetes after 3 weeks of hot tub therapy (30 min for 3 weeks, 6 days in a week) [15]. Obese subjects also showed a decrease in fasting blood glucose after sauna therapy for 2 weeks, 15 min/day at 60 °C [16]. These reports together with our animal studies mentioned above encouraged us to apply MES + HS treatment for human subjects with type 2 diabetes.

First, the safety of the HS + MES treatment [42 °C pads and 12-V direct current (55 pulses/s with 0.1-ms duration) for 30 min, four times per week for 8 weeks] was investigated in healthy volunteers. As a result, not only the safety of the method but also reduced inflammatory markers (TNF-α and CRP) were confirmed in ten healthy Japanese males [17]. In 40 Japanese male subjects with metabolic syndrome, treatment with HS + MES [42 °C pads and 1.4 ± 0.1 V/cm direct current (55 pulses/s with 0.1 ms duration) for 60 min, four times per week for 12 weeks] significantly reduced fasting blood glucose and insulin levels, visceral fat, circulating inflammatory markers and blood pressure [18]. Moreover, in 40 Japanese male subjects with type 2 diabetes, the same treatment with HS + MES significantly reduced HbA1c levels by −0.43 % in addition to the improvements of various metabolic parameters as observed in the subjects with metabolic syndrome [18]. Although we could not investigate the impact of HS + MES treatment in either the liver or fat of these subjects, increased expression of HSP72, decreased activation of JNK and decreased mRNA expression of CRP, NF-κB and TNF-α were confirmed in monocytes after the treatment with HS + MES in the subjects with type 2 diabetes.

Future perspectives

We and others have previously reported that overburdening the endoplasmic reticulum (ER) stress response pathway, which is another cellular stress response pathway, is involved in the development and progression of diabetes [19, 20]. Induction of a molecular chaperone to reduce the overburdening on ER stress was reported to ameliorate the diabetic phenotype in an animal model of diabetes [21]. Both the ER stress response and heat shock response pathways are essentially involved in the defense to protect us from various stresses; therefore, the approaches to strengthen such cellular response pathways could provide us with novel therapeutic strategies to prevent the development and progression of type 2 diabetes.

Notes

Compliance with ethical standards

Human rights statement and informed consent

This article does not contain any original studies with human or animal subjects performed by any of the authors.

Conflict of interest

Eiichi Araki has received speaker honoraria from Astellas Pharma Inc. and Mitsubishi Tanabe Pharma Co. as well as scholarship grants from Astellas Pharma Inc., Daiichi-Sankyo Co., Ltd., AstraZeneca K.K. and Takeda Pharmaceutical Co. Tatsuya Kondo and Hirofumi Kai have no conflict of interest.

References

  1. 1.
    Romeo GR, Lee J, Shoelson SE. Metabolic syndrome, insulin resistance, and roles of inflammation-mechanisms and therapeutic targets. Arterioscler Thromb Vasc Biol. 2012;32(8):1771–6.CrossRefPubMedGoogle Scholar
  2. 2.
    Hirosumi J, Tuncman G, Chang L, et al. A central role for JNK in obesity and insulin resistance. Nature. 2002;420:333–6.CrossRefPubMedGoogle Scholar
  3. 3.
    Morimoto RI, Kline MP, Bimston DN, Cotto JJ. The heat-shock response: regulation and function of heat-shock proteins and molecular chaperones. Essays Biochem. 1997;32:17–29.PubMedGoogle Scholar
  4. 4.
    Morimoto RI. Cells in stress: Transcriptional activation of heat shock genes. Science. 2003;259:1409–10.CrossRefGoogle Scholar
  5. 5.
    Kurucz I, Morva A, Vaag A, Eriksson KF, Huang X, Groop L, et al. Decreased expression of heat shock protein 72 in skeletal muscle of patients with type 2 diabetes correlates with insulin resistance. Diabetes. 2002;51(4):1102–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Hooper PL, Balogh G, Rivas E, Kavanagh K, Vigh L. The importance of the cellular stress response in the pathogenesis and treatment of type 2 diabetes. Cell Stress Chaperones. 2014;19(4):447–64.PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Chung J, Nguyen AK, Henstridge DC, et al. HSP72 protects against obesity induced insulin resistance. Proc Natl Acad Sci USA. 2008;105(5):1739–44.PubMedCentralCrossRefPubMedGoogle Scholar
  8. 8.
    Henstridge DC, Bruce CR, Drew BG, et al. Activating HSP72 in rodent skeletal muscle increases mitochondrial number and oxidative capacity and decreases insulin resistance. Diabetes. 2014;63(6):1881–94.PubMedCentralCrossRefPubMedGoogle Scholar
  9. 9.
    Gupta S, Deepti A, Deegan S, Lisbona F, Hetz C, Samali A. HSP72 protects cells from ER stress-induced apoptosis via enhancement of IRE1alpha-XBP1 signaling through a physical interaction. PLoS Biol. 2010;8(7):e1000410.PubMedCentralCrossRefPubMedGoogle Scholar
  10. 10.
    Morino S, Kondo T, Sasaki K, et al. Mild electrical stimulation with heat shock ameliorates insulin resistance via enhanced insulin signaling. PLoS ONE. 2008;3(12):e4068.PubMedCentralCrossRefPubMedGoogle Scholar
  11. 11.
    Morino S, Suico MA, Kondo T, et al. Mild electrical stimulation increases ubiquitinated proteins and Hsp72 in A549 cells via attenuation of proteasomal degradation. J. Pharmacol. Sci. 2008;108(2):222–6.CrossRefPubMedGoogle Scholar
  12. 12.
    Morino-Koga S, Yano S, Kondo T, et al. Insulin receptor activation through its accumulation in lipid rafts by mild electrical stress. J Cell Physiol. 2013;228(2):439–46.CrossRefPubMedGoogle Scholar
  13. 13.
    Adachi H, Kondo T, Ogawa R, et al. An acylic polyisoprenoid derivative, geranylgeranylacetone protects against visceral adiposity and insulin resistance in high fat fed mice. Am J Physiol Endocrinol Metab. 2010;299(5):E764–71.CrossRefPubMedGoogle Scholar
  14. 14.
    Kondo T, Sasaki K, Matsuyama R, et al. Hyperthermia with mild electrical stimulation protects pancreatic beta-cells from cell stresses and apoptosis. Diabetes. 2012;61(4):838–47.PubMedCentralCrossRefPubMedGoogle Scholar
  15. 15.
    Hooper PL. Hot-tub therapy for type 2 diabetes mellitus. N Engl J Med. 1999;341:924–5.CrossRefPubMedGoogle Scholar
  16. 16.
    Biro S, Masuda A, Kihara T. Tei C Clinical implications of thermal therapy in lifestyle-related diseases. Exp Biol Med. 2003;228(10):1245–9.Google Scholar
  17. 17.
    Kondo T, Sasaki K, Adachi H, et al. Heat shock treatment with mild electrical stimulation safely reduced inflammatory markers in healthy male subjects. Obes Res Clin Pract. 2010;4(2):e101–9.Google Scholar
  18. 18.
    Kondo T, Ono K, Kitano S, Matsuyama R, Goto R, Suico M, Kawasaki S, Igata M, Kawashima J, Motoshima H, Matsumura T, Kai H, Araki E. Mild electrical stimulation with heat shock reduces visceral adiposity and improves metabolic abnormalities in subjects with metabolic syndrome or type 2 diabetes: randomized crossover trials. EBioMedicine. 2014;1(1):80–9.Google Scholar
  19. 19.
    Araki E, Oyadomari S, Mori M. Impact of endoplasmic reticulum stress pathway on pancreatic beta-cells and diabetes mellitus. Exp Biol Med. 2003;228(10):1213–7.Google Scholar
  20. 20.
    Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, Tuncman G, Görgün C, Glimcher LH, Hotamisligil GS. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 2004;306(5695):457–61.CrossRefPubMedGoogle Scholar
  21. 21.
    Kammoun HL, Chabanon H, Hainault I, Luquet S, Magnan C, Koike T, Ferré P, Foufelle F. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J Clin Invest. 2009;119(5):1201–15.PubMedCentralCrossRefPubMedGoogle Scholar

Copyright information

© The Japan Diabetes Society 2015

Authors and Affiliations

  1. 1.Department of Metabolic Medicine, Faculty of Life SciencesKumamoto UniversityChuoJapan
  2. 2.Department of Molecular Medicine, Faculty of Life SciencesKumamoto UniversityKumamotoJapan

Personalised recommendations